Informed consent for a prescription drug: impact of disclosed information on patient understanding and medical outcomes.
D000328:Adult; D000367:Age Factors; D000533:Altruism; D001290:Attitude; D015142:Baltimore; D026686:Beneficence; D002220:Carbamazepine; D002648:Child; D003071:Cognition; D032882:Comprehension; D003625:Data Collection; D003657:Decision Making; D030881:Disclosure; D004827:Epilepsy; D005069:Evaluation Studies as Topic; D005610:Freedom; D006266:Health Education; D006801:Humans; D007258:Informed Consent; D007603:Jurisprudence; D011939:Mental Recall; D033282:Parental Consent; D010290:Parents; D005791:Patient Care; D010358:Patient Participation; D010361:Patients; D010372:Pediatrics; D026684:Personal Autonomy; D004364:Pharmaceutical Preparations; D010820:Physicians; D012015:Reference Standards; D012306:Risk; D018570:Risk Assessment; D012945:Social Values; D013223:Statistics as Topic; D013315:Stress, Psychological; D020458:Third-Party Consent; D016312:Treatment Refusal; D014481:United States
Empirical Approach; Johns Hopkins Hospital (Baltimore, MD); Professional Patient Relationship